Company Filing History:
Years Active: 2006
Title: The Innovations of Robert A. Britton
Introduction
Robert A. Britton is a notable inventor based in Cambridge, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimitotic compounds. His work focuses on enhancing the efficacy and delivery of therapeutic agents.
Latest Patents
Robert A. Britton holds a patent for "Antimitotic eleuthesides." This invention provides analogs of eleutherobin and the eleuthesides modified at the C-11 position or comprising an epoxide functionality from C-11 to C-12. The C-11 to C-12 region is an ideal location for conjugating functional moieties to the eleutherobin pharmacophore without significant loss of antimitotic activity. Moieties that may be conjugated at C-11 include those intended to increase the solubility of the pharmacophore, facilitate drug formulation, or enhance in vivo delivery or targeting. He has 1 patent to his name.
Career Highlights
Robert A. Britton is affiliated with the University of British Columbia, where he continues to engage in innovative research. His work has implications for cancer treatment, showcasing his commitment to advancing medical science.
Collaborations
He has collaborated with notable colleagues such as Raymond John Andersen and Michel Roberge, contributing to a rich environment of innovation and discovery.
Conclusion
Robert A. Britton's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant figure in the advancement of medical research. His work continues to inspire future developments in drug formulation and delivery.